Literature DB >> 25022858

Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.

Paul H Chung1, Laura-Maria Krabbe2, Oussama M Darwish1, Mary E Westerman1, Aditya Bagrodia1, Bishoy A Gayed1, Ahmed Q Haddad1, Payal Kapur3, Arthur I Sagalowsky1, Yair Lotan1, Vitaly Margulis4.   

Abstract

OBJECTIVE: To evaluate degree of hydronephrosis (HN) as a surrogate for adverse pathological features and oncologic outcomes in patients with high-grade (HG) and low-grade (LG) upper tract urothelial carcinomas (UTUCs).
METHODS: We retrospectively reviewed 141 patients with localized UTUCs that underwent extirpative surgery at a tertiary referral center. Preoperative imaging was used to evaluate presence and degree of ipsilateral HN. We evaluated degree of HN (none/mild vs. moderate/severe), pathological findings, and oncologic outcomes.
RESULTS: HG UTUC was present in 113 (80%) patients, muscle-invasive disease (≥pT2) in 49 (35%), and non-organ-confined disease (≥pT3) in 41 (29%). At a median follow-up of 34 months, 49 (35%) patients experienced intravesical recurrence, 28 (20%) developed local/systemic recurrence, and 24 (17%) died of UTUC. HN was graded as none/mild in 77 (55%) patients and moderate/severe in 64 (45%). In patients with HG UTUC, but not LG, degree of HN was associated with advanced pathological stage (P<0.001), positive lymph nodes (P = 0.01), local/systemic recurrence-free survival (hazard ratio [HR] = 5.5, P = 0.02), and cancer-specific survival (HR = 5.2, P = 0.02). On multivariable analysis of preoperative factors, degree of HN in patients with HG UTUC was associated with muscle invasion (HR = 9.3; 95% CI: 3.08-28.32; P<0.001), non-organ-confined disease (HR = 4.5; 95% CI: 1.66-12.06; P = 0.003), local/systemic recurrence-free survival (HR = 2.5; 95% CI: 1.07-5.64; P = 0.04), and cancer-specific survival (HR = 2.6; 95% CI: 1.05-6.22; P = 0.04).
CONCLUSIONS: Degree of HN can serve as a surrogate for advanced disease and predict worse oncologic outcomes in HG UTUC. Degree of HN was not predictive of intravesical or local/systemic recurrence in LG UTUC.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Hydronephrosis; Nephroureterectomy; Outcome; Upper tract urothelial carcinoma

Mesh:

Year:  2014        PMID: 25022858     DOI: 10.1016/j.urolonc.2014.02.018

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  17 in total

Review 1.  Use of percutaneous nephrostomy and ureteral stenting in management of ureteral obstruction.

Authors:  Linda Hsu; Hanhan Li; Daniel Pucheril; Moritz Hansen; Raymond Littleton; James Peabody; Jesse Sammon
Journal:  World J Nephrol       Date:  2016-03-06

2.  Preoperative hydronephrosis as a predictor of postnephroureterectomy survival in patients with upper tract urothelial carcinoma: a two-center study in Japan.

Authors:  Tomohiro Fukui; Toru Kanno; Go Kobori; Seiji Moroi; Hitoshi Yamada
Journal:  Int J Clin Oncol       Date:  2019-09-03       Impact factor: 3.402

Review 3.  [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].

Authors:  C Netsch; B Becker; A J Gross
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

Review 4.  Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC).

Authors:  Francesco Soria; Shahrokh F Shariat; Seth P Lerner; Hans-Martin Fritsche; Michael Rink; Wassim Kassouf; Philippe E Spiess; Yair Lotan; Dingwei Ye; Mario I Fernández; Eiji Kikuchi; Daher C Chade; Marko Babjuk; Arthur P Grollman; George N Thalmann
Journal:  World J Urol       Date:  2016-09-07       Impact factor: 4.226

5.  Comparisons of prognosis between urothelial carcinoma of the upper urinary tract and bladder with pT3-4 cancer.

Authors:  Xiaohong Su; Qi Tang; Dong Fang; Gengyan Xiong; Nirmish Singla; Qun He; Lei Zhang; Pei Liu; Yu Fan; Han Hao; Xuesong Li; Liqun Zhou
Journal:  Int J Clin Exp Med       Date:  2016-09-30

6.  Concurrent Preoperative Presence of Hydronephrosis and Flank Pain Independently Predicts Worse Outcome of Upper Tract Urothelial Carcinoma.

Authors:  Hsin-Chih Yeh; Hau-Chern Jan; Wen-Jeng Wu; Ching-Chia Li; Wei-Ming Li; Hung-Lung Ke; Shu-Pin Huang; Chia-Chu Liu; Yung-Chin Lee; Sheau-Fang Yang; Peir-In Liang; Chun-Nung Huang
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

7.  Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.

Authors:  Jian-Ye Liu; Ying-Bo Dai; Fang-Jian Zhou; Zhi Long; Yong-Hong Li; Dan Xie; Bin Liu; Jin Tang; Jing Tan; Kun Yao; Le-Ye He
Journal:  BMC Surg       Date:  2017-01-17       Impact factor: 2.102

8.  Prediction of high-grade ureteral urothelial carcinoma on CT urography.

Authors:  Hwang Sung Tae; Sung Deuk Jae; Yang Kyung Sook; Sim Ki Choon; Han Na Yeon; Park Beom Jin; Kim Min Ju; Cho Sung Bum
Journal:  Br J Radiol       Date:  2017-08-22       Impact factor: 3.039

Review 9.  Why are upper tract urothelial carcinoma two different diseases?

Authors:  Tibor Szarvas; Orsolya Módos; András Horváth; Péter Nyirády
Journal:  Transl Androl Urol       Date:  2016-10

10.  Clinical and prognostic value of preoperative hydronephrosis in upper tract urothelial carcinoma: a systematic review and meta-analysis.

Authors:  Yuejun Tian; Yuwen Gong; Yangyang Pang; Zhiping Wang; Mei Hong
Journal:  PeerJ       Date:  2016-06-21       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.